Dr Reddy's Q2 net profit down 17 per cent at Rs 574.1 crore
The pharma major’s global generics business grew by just 9% against market estimate of 15-20% growth. Its revenues from Europe was down 19% while those from Russia fell 13%.
READ MORE:
Other Results Videos
Maruti Suzuki Q3 Results: PAT jumps 33% YoY to Rs 3,207 cr; revenue up 15%
L&T Q3 Results: Net profit rises 16% YoY to Rs 2,947 cr; revenue up 19%
L&T Q3 results Preview: Here's what to expect from infrastructure major
Dr Reddy's Q3 Results: Profit meets estimates, jumps 11% YoY to Rs 1,379 cr; revenue up 7%
ITC Q3 Results: Profit rises 6% YoY to Rs 5,335 cr; co declares Rs 6.25/share dividend
